Meitheal Pharmaceuticals, Inc
Meitheal Pharmaceuticals, Inc has 3 FDA enforcement events on this register (3 product records) between 2021 and 2026: 3 drug; the busiest year was 2021 with 2.
33% of its events are Class I; the most common class is Class I (1). 1 event is listed as ongoing; the recalling firm's address is in IL.
Recall classification reflects the relative degree of health hazard. Event counts depend on a firm's size and product range; they are not a comparison of one firm with another.
Enforcement events
| Initiated | Product (first record) | Type | Class | Records | Status |
|---|---|---|---|---|---|
| 9 Feb 2026 | Cetrorelix Acetate for Injection (Kit), 0.25 mg per vial, Single-Dose Kit, Rx Only, Mfd. for: Meitheal Pharmaceuticals, Chicago, IL NDC 71288-558-90. | Drug | Class II | 1 | Ongoing |
| 3 Sep 2021 | Glycopyrrolate Injection, USP 4mg per 20mL, 20 mL Multi-Dose Vials, Rx only, Mfd for Meitheal Pharmaceuticals, Chicago, IL 60631. NDC 71288-408-21 | Drug | Class III | 1 | Terminated |
| 27 Jan 2021 | Cisatracurium Besylate Injection, USP, 10mg per 5mL (2 mg per mL), Single-Dose Vial (NDC 71288-712-05), packaged as 10 x 5 mL Single-Dose Vials per carton (NDC 71288-712-06), Rx only, Mfd. for Meitheal Pharmaceuticals, Chicago, IL 60631. | Drug | Class I | 1 | Terminated |
By type and class
Class I: 33% of this firm's events; 18% of all events on the register.
Events by year
Questions and answers
How many FDA recalls has Meitheal Pharmaceuticals, Inc had?
3 enforcement events (3 product records) on this register, 2021–2026: 3 drug.
Are any Meitheal Pharmaceuticals, Inc recalls ongoing?
1 event is listed as ongoing in the current openFDA export.
What class are Meitheal Pharmaceuticals, Inc recalls?
1 Class I, 1 Class II, 1 Class III. 33% are Class I against 18% of all events on the register. Class reflects the relative degree of health hazard of the product, not the firm.
Where does this data come from?
openFDA food, drug and device enforcement reports (CC0), export dated 28 Sep 2026.
Provenance
Source: openFDA enforcement reports (CC0), export dated 28 Sep 2026. Firm names are grouped exactly as FDA spells them; the same company can appear under several spellings. Only organisations are shown. See the methodology.